Are Pemigatinib tablets available for sale?

Pemigatinib (Pemigatinib) is a fibroblast growth factor (FGF) receptor kinase inhibitor used to treat unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma, as well as myeloid or lymphoid tumors with FGFR rearrangements. Pemetinib is associated with transient and usually mild to moderate increases in serum aminotransferase levels during treatment but has not been shown to be associated with cases of clinically apparent liver injury with jaundice. Pemetinib works by helping to block the activity of the abnormal FGFR2 protein, which may help shrink cholangiocarcinoma tumors or make them disappear. This doesn't always mean the cancer is cured. FGFR2 is a gene that makes proteins involved in cell growth. Abnormal changes in the FGFR2 gene may cause the protein to become overactive, leading to certain cancers, including cholangiocarcinoma.

The original drug Pemetinib has been launched in China. Due to its short time on the market, it has not yet entered the scope of medical insurance. The price of each box of 9mg*14 tablets may be around 50,000 yuan, which is expensive. This drug may be sold in domestic hospitals or pharmacies. The original drug Pemetinib currently on the market overseas, with a specification of 13.5mg*14 tablets, may cost around RMB 70,000 per box (the price may fluctuate due to exchange rates). There are also generic pemetinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold abroad. For example, the price of 4.5mg*14 tablets per box produced by a Laos pharmaceutical factory may be around 1,000 yuan (the price may fluctuate due to exchange rates). For more drug information and specific prices, please consult Yaode Medical Consultant.